Search
forResearch 10 of 1000+
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- What causes hidradenitis suppurativa ?—15 years after
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →